It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
More at: www.statnews.com...
The efficacy of the Covid-19 vaccine developed by Pfizer and BioNTech fell from 96% to 84% over six months, according to data released Wednesday, a decline that could fuel Pfizer’s case that a third dose will eventually be required.
www.reuters.com... ws-idUSL4N2PI4E3
(Reuters) - The U.S. Food and Drug Administration is expected to authorize a third booster dose of COVID-19 vaccines by Pfizer Inc and Moderna Inc for people with weakened immune systems, NBC News reported on Wednesday.
The health agency will amend the emergency use authorizations for the two vaccines as soon as Thursday to allow immunocompromised people to get an additional dose, the report said, citing people familiar with the matter.
In this context, the success of the Novavax vaccine should be A1 news. The recent results confirm that it has roughly the same efficacy as the two authorized mRNA vaccines, with the added benefit of being based on an older, more familiar science. The protein-subunit approach used by Novavax was first implemented for the hepatitis B vaccine, which has been used in the U.S. since 1986. The pertussis vaccine, which is required for almost all children in U.S. public schools, is also made this way. Some of those people who have been wary of getting the mRNA vaccines may find Novavax more appealing.
The Novavax vaccine also has a substantially lower rate of side effects than the authorized mRNA vaccines.
Among several wonderful options, the more old-school vaccine from Novavax combines ease of manufacture with high efficacy and lower side effects. For the moment, it’s the best COVID-19 vaccine we have.
originally posted by: Irishhaf
Ive had 2 different Neurosurgeons suggest a booster shot would be a bad idea until a lot more data had been collected to give a better idea of long term impact on a persons health. Assuming they do not have a secondary health issue that put them in the very high risk category.
originally posted by: IAMTAT
a reply to: carewemust
The World Health Organization is already planning for MORE than 25 new variants.
Boosters are never going to stop.
originally posted by: carewemust
Of 600,000 listed as Covid-19 deaths, 564,000 of them had "secondary health issues". Co-morbidities, as they're called, are very common.
originally posted by: IAMTAT
a reply to: carewemust
The World Health Organization is already planning for MORE than 25 new variants.
Boosters are never going to stop.
originally posted by: LordAhriman
originally posted by: carewemust
Of 600,000 listed as Covid-19 deaths, 564,000 of them had "secondary health issues". Co-morbidities, as they're called, are very common.
Again, "co-morbitities" are symptoms. There should never be just a virus listed on a death certificate. Ever. Pneumonia was the most common comorbidity with covid, as it does attack your lungs.
Also, Novavax has to get EUA status and I have a feeling that the bought and paid for FDA will deny them because we "already have Pfizer".
originally posted by: infolurker
a reply to: carewemust
I am actually more concerned that Pfizer is going to be fast tracked through approval and it will be the only "authorized" vaccine available in the United States.
Also, Novavax has to get EUA status and I have a feeling that the bought and paid for FDA will deny them because we "already have Pfizer".
The current manufacturers KNOW that people will migrate over to the safer technology vaccine and they will lose billions so due to that, I expect the FDA payoff to keep NovaVax out of the US market.
I guess we will wait and see.